The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has started the week on a positive note, up 0.69% at 8,080 points.

Real Estate, Discretionary, Financials and Telecommunications have all been leading, up around 1%. Staples has been the worst performer, down 0.8%.

Company News

Plilbara Minerals (ASX:PLS) has been the most viewed on HotCopper, trading up around a third of a percent (0.34%), despite considerably lower revenue in FY24.

Its profit after tax was 89% lower, but the company increased production by 17% and its sales by nearly as much.

Pilbara Minerals has been trading at $2.99.

Nova Eye Medical (ASX:EYE) has been trading up more than 2% after reporting solid sales growth in improved FY24 results, but still lodged a $5.7 million loss.

The company’s sales spiked 35% and earnings before costs increased 33%.  The loss of $5.7 million was a $3 million turnaround from FY23.

Nova Eye Medical has been swapping hands at 23 cents.

Rincon Resources (ASX:RCR) has been down more than 7% off a low base after detecting niobium and rare earth elements at its West Arrunta Project in WA.

The results are preliminary and the assays are now at the lab for formal analysis.

Rincon Resources has been trading at 3.6 cents.

And Kelsian Group (ASX:KLS) has been down more than 25% after releasing FY24 results. The strong investor write down has been a reaction to the company’s announced investment in several strategic initiatives.

The company is revising its capital investment program for FY25 up as high as $190 million, and includes acquiring a bus depot in Sydney, new buses, ferries and vessels.

Kelsian Group has been trading at $3.75.

More From The Market Online
Market Close Graphic

ASX Market Close: IT stocks lead bourse higher | November 8, 2024

The market remains buoyant in the wake of Trump’s election in the United States, and the…
Golden sun across a mountain ridge

Flynn Gold reaches milestone exploration target for Golden Ridge

Flynn Gold Ltd has achieved a maiden exploration target for the Trafalgar, Brilliant and Link Zone…
Image of t-cells

Imugene kicks off Australian trial for blood cancer treatment

Imugene Ltd has opened its first Australian trial for a Phase 1b clinical trial to test…
Market Update Graphic

ASX Market Update: Index surges towards record high | November 8, 2024

Gold stocks have bounced back today in response to a resurgent gold price. The safe-haven precious…